Rehan Haidry

Appearances

DUODENAL MUCOSAL RESURFACING: A FRESH START FOR DIABETICS?
Date
May 6, 2023
SOCIETY: ASGE
Presenter
Rehan Haidry
ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: INTERIM RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
Date
May 9, 2023
Current guidelines advise esophagectomy for submucosal esophageal adenocarcinoma (T1b EAC). However, data from retrospective studies suggest that endoscopic follow-up (FU) may be a valid alternative in patients without signs of lymph node metastases (LNM) at baseline…
Presenter
Man Wai Chan
Speakers
Esther Nieuwenhuis
Marnix Jansen
Arjun Koch
Manon Spaander
Wouter Nagengast
Jessie Westerhof
Raf Bisschops
Gert De Hertogh
Michael Bourke
Westmead hospital, University of Sydney
Horst Neuhaus
Bas Weusten
A. Alkhalaf
Oliver Pech
Stefan Seewald
Rehan Haidry
Christoph Schlag
Erik Schoon
Martin Houben
Dominiek De Wulf
Helmut Messmann
Universitatsklinikum Augsburg
Pieter Dewint
Sybren Meijer
Jacques Bergman
Roos Pouw
ENDOSCOPIC ERADICATION THERAPY WITH MULTIFOCAL CRYOBALLOON ABLATION FOR BARRETT'S ESOPHAGUS RELATED NEOPLASIA: PRELIMINARY RESULTS FROM A PROSPECTIVE EUROPEAN MULTICENTER STUDY
Date
May 7, 2023
Focal cryoballoon ablation (FCBA) is a relatively new ablation modality for the treatment of Barrett’s esophagus (BE) related neoplasia. This prospective, European multicenter study (Euro-Coldplay, NTR NL7253) aimed to evaluate the efficacy and safety of FCBA for the treatment of limited BE…
Presenter
Charlotte Frederiks
Speakers
Anouk Overwater
Maximilien Barret
Roberta Maselli
Jacques Bergman
Roos Pouw
Raf Bisschops
Rehan Haidry
Vinay Sehgal
Torsten Beyna
Horst Neuhaus
Bas Weusten